A lay summary of the trial results can be found on the Cancer Research UK website see Other Websites for the link.
A list of published papers and abstracts is below:
Olavarria E, Siddique S, et al. . Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia. (2007) Blood 110(13): 4614-7.
Craddock C, Olavarria E, Griffiths M, Arrazi JM, Siddique S, Lennard A, Byrne J. Combined tyrosine kinase inhibition and immunotherapy as a strategy to improve outcome after reduced intensity allogeneic stem cell transplantation in chronic myeloid leukaemia (CML). Abstr. 0437, EHA 2006, Amsterdam.
Craddock CF, Griffiths MJ, Arrazi JM, Siddique S, Pallan L, Lennard AL, Byrne JL, Olavarria E. The Use of Adjunctive Leukemia Specific Therapy To Improve Outcome in Patients with Chronic Myeloid Leukemia Transplanted Using a Reduced Intensity Conditioning (RIC) Regimen. Poster 357, CIBMTR 2007.